Iron Chelation Therapy
Also known as: chelation therapy.
What is iron chelation therapy?
Iron chelation therapy is a treatment used to remove excess iron from the blood. When individuals have to get many blood transfusions, iron overload can become a problem for them. When people have sickle cell disease, iron chelation therapy in the form of deferoxamine (Jadenu) has been shown to enhance iron excretion and remove excess tissue iron in regularly transfused patients.
What happens during the treatment?
Older forms of iron chelation therapy come in the form of an infusion pump that must be worn for 8 to 12 hours in order to inject the medication into the body. Newer forms of iron chelation therapy come in a tablet form that is either taken with juice or water or simply swallowed once a day. These newer forms of iron chelation therapy have good tolerance and are becoming the preferred method of treatment. Jadenu is one of these tablet forms of iron chelation therapy.
Is any special preparation needed?
Tests are needed in advance to determine if iron chelation therapy treatment is needed. Some of the treatments, such as Jadenu, must be taken on an empty stomach.
What are the risk factors?
Dizziness, nausea, vomiting, diarrhea, rash and hearing or vision problems are potential side effects of iron chelation therapy.
Reviewed by: Athena C Pefkarou, MD
This page was last updated on: November 06, 2020 02:42 PM
Learn more about
Beta Thalassemia Major
Beta thalassemia is an abnormality in the production of beta chains which causes the red cells to more easily breakdown resulting in mild to severe anemia. It is more common in Mediterranean (Italian or Greek), African or Southeast Asian peoples
Hgb E/B 0 Thalassemia
When someone has both abnormal hemoglobin and thalassemia, one possibility is that they have Hgb E/B 0 thalassemia.
Chronic Transfusion Therapy/Hypertransfusion Therapy
Chronic transfusion therapy is a form of blood transfusion that is repeated on a “chronic,” or regular, basis.
Hypertransfusion management is a form of blood transfusion that’s aimed at reducing the risk of complications such as stroke in patients with sickle cell disease.